314 related articles for article (PubMed ID: 37801187)
1. Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives.
Dłubak A; Karwacki J; Logoń K; Tomecka P; Brawańska K; Krajewski W; Szydełko T; Małkiewicz B
Curr Oncol Rep; 2023 Nov; 25(11):1327-1344. PubMed ID: 37801187
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of
Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
[TBL] [Abstract][Full Text] [Related]
3. Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023.
Yanagisawa T; Kawada T; von Deimling M; Laukhtina E; Kimura T; Shariat SF
Curr Opin Urol; 2023 Jul; 33(4):258-268. PubMed ID: 37014743
[TBL] [Abstract][Full Text] [Related]
4. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
[TBL] [Abstract][Full Text] [Related]
5. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
[TBL] [Abstract][Full Text] [Related]
6. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
[TBL] [Abstract][Full Text] [Related]
7. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
8. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
[TBL] [Abstract][Full Text] [Related]
9. Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.
Campi R; Minervini A; Mari A; Hatzichristodoulou G; Sessa F; Lapini A; Sessa M; Gschwend JE; Serni S; Roscigno M; Carini M
Expert Rev Anticancer Ther; 2017 Mar; 17(3):235-246. PubMed ID: 28103449
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Roscigno M; Brausi M; Heidenreich A; Lotan Y; Margulis V; Shariat SF; Van Poppel H; Zigeuner R
Eur Urol; 2011 Oct; 60(4):776-83. PubMed ID: 21798659
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of lymphadenectomy in upper tract urothelial carcinoma.
Weight CJ; Gettman MT
Urol Clin North Am; 2011 Nov; 38(4):429-37, vi. PubMed ID: 22045174
[TBL] [Abstract][Full Text] [Related]
13. Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.
Sato R; Watanabe K; Matsushita Y; Watanabe H; Motoyama D; Ito T; Sugiyama T; Otsuka A; Miyake H
Urologia; 2022 Aug; 89(3):354-357. PubMed ID: 34325582
[TBL] [Abstract][Full Text] [Related]
14. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
15. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
[TBL] [Abstract][Full Text] [Related]
16. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.
Moschini M; Foerster B; Abufaraj M; Soria F; Seisen T; Roupret M; Colin P; De la Taille A; Peyronnet B; Bensalah K; Herout R; Wirth MP; Novotny V; Chlosta P; Bandini M; Montorsi F; Simone G; Gallucci M; Romeo G; Matsumoto K; Karakiewicz P; Briganti A; Shariat SF
World J Urol; 2017 Oct; 35(10):1541-1547. PubMed ID: 28247066
[TBL] [Abstract][Full Text] [Related]
17. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
[TBL] [Abstract][Full Text] [Related]
19. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
Lange S; Calleris G; Matin SF; Rouprêt M
Eur Urol Focus; 2023 Mar; 9(2):280-282. PubMed ID: 36642620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
